SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3,056.93 |
Enterprise Value ($M) | 3,076.94 |
Book Value ($M) | 160.11 |
Book Value / Share | 1.12 |
Price / Book | 19.09 |
NCAV ($M) | 165.51 |
NCAV / Share | 1.15 |
Price / NCAV | 18.47 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.35 |
Return on Assets (ROA) | 0.29 |
Return on Equity (ROE) | 2.37 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.83 |
Current Ratio | 3.58 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 389.15 |
Assets | 401.21 |
Liabilities | 223.64 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock, Inc. | 14.20 | ||
13G/A | Darwin Global Management, Ltd. | 2.70 | -61.28 | |
13G/A | Vanguard Group Inc | 9.03 | -11.82 | |
13G/A | BlackRock Inc. | 7.10 | 17.91 | |
13G/A | State Street Corp | 5.45 | -20.75 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
476,518 | 1,987,278 | 23.98 | |
628,661 | 1,861,783 | 33.77 | |
533,997 | 2,038,882 | 26.19 | |
302,176 | 1,032,900 | 29.26 | |
(click for more detail) |
Similar Companies | |
---|---|
TELO – Telomir Pharmaceuticals, Inc. | TENX – Tenax Therapeutics, Inc. |
TFFP – TFF Pharmaceuticals, Inc. | THAR – Tharimmune, Inc. |
THTX – Theratechnologies Inc. |